Spiro[2.5]octane-6-carboxylic acid, 95.0%, 1g

4-Methoxy-2,6-dimethylphenylboronic Acid (contains varying amounts of Anhydride)1g

Pipetta multicanale per microlitri Pipetman® L a 8 canali, da 20 a 300 µl, P8x300L, 1 pezzo

(S)-TETRAHYDROFURAN-3-YL ((2S,3R)-4-(4-AMINO-N-ISOBUTYLPHENYLSULFONAMIDO)-1-PHENYL-3-(PHOSPHONOOXY)BUTAN-2-YL)CARBAMATE, 99%, 100mg

(5E)-5-(4-isopropylbenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 1g

N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-bis((tert-butyldimethylsilyl)oxy)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95%, 5g

tert-Butyl 4-amino-4-cyanopiperidine-1-carboxylate, 95.0%, 5g

(S)-1-((S)-2-(3,4,5-Trimethoxyphenyl)butanoyl)piperidine-2-carboxylic acid, 97%, 250mg

Valeric Acid>98.0%(GC)(T)25mL

(E)-2-(2,4-Difluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

(S)-benzyl (1-(4-phenyl-1H-imidazol-2-yl)ethyl)carbamate, 97%, 10g

N-hydroxy-1-[(4-methoxyphenyl)methyl]indole-6-carboxamide, 98%, 250mg

8-Hydroxyquinoline-N-oxide, 97.0%, 5g